Fisher & Paykel Healthcare Corporation Limited (NZ:FPH)
:FPH
Want to see NZ:FPH full AI Analyst Report?
Total Valuation
Fisher & Paykel Healthcare Corporation Limited has a market cap or net worth of $19.67B. The enterprise value is $19.82B.
Market Cap$19.67B
Enterprise Value$19.82B
Share Statistics
Fisher & Paykel Healthcare Corporation Limited has 587,289,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding587,289,000
Owned by Insiders0.17%
Owned by Institutions―
Financial Efficiency
Fisher & Paykel Healthcare Corporation Limited’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 17.87%.
Return on Equity (ROE)0.20
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)17.87%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee267.99K
Profits Per Employee50.02K
Employee Count6,978
Asset Turnover0.79
Inventory Turnover2.19
Valuation Ratios
The current PE Ratio of Fisher & Paykel Healthcare Corporation Limited is 25.5. Fisher & Paykel Healthcare Corporation Limited’s PEG ratio is 0.36.
PE Ratio25.5
PS Ratio10.50
PB Ratio11.23
Price to Fair Value11.23
Price to FCF44.68
Price to Operating Cash Flow36.81
PEG Ratio0.36
Income Statement
In the last 12 months, Fisher & Paykel Healthcare Corporation Limited had revenue of 1.87B and earned 349.03M in profits. Earnings per share was 0.59.
Revenue1.87B
Gross Profit1.18B
Operating Income471.54M
Pretax Income465.71M
Net Income349.03M
EBITDA576.01M
Earnings Per Share (EPS)0.59
Cash Flow
In the last 12 months, operating cash flow was 537.83M and capital expenditures -83.46M, giving a free cash flow of 454.37M billion.
Operating Cash Flow537.83M
Free Cash Flow454.37M
Free Cash Flow per Share0.77
Dividends & Yields
Fisher & Paykel Healthcare Corporation Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.49
52-Week Price Change-6.65%
50-Day Moving Average36.82
200-Day Moving Average37.44
Relative Strength Index (RSI)35.33
Average Volume (3m)497.99K
Important Dates
Fisher & Paykel Healthcare Corporation Limited upcoming earnings date is May 25, 2026, After Close (Confirmed).
Last Earnings DateNov 25, 2025
Next Earnings DateMay 25, 2026
Ex-Dividend Date―
Financial Position
Fisher & Paykel Healthcare Corporation Limited as a current ratio of 1.87, with Debt / Equity ratio of 7.46%
Current Ratio1.87
Quick Ratio1.18
Debt to Market Cap<0.01
Net Debt to EBITDA-0.18
Interest Coverage Ratio43.30
Taxes
In the past 12 months, Fisher & Paykel Healthcare Corporation Limited has paid 116.68M in taxes.
Income Tax116.68M
Effective Tax Rate0.25
Enterprise Valuation
Fisher & Paykel Healthcare Corporation Limited EV to EBITDA ratio is 33.92, with an EV/FCF ratio of 44.45.
EV to Sales10.45
EV to EBITDA33.92
EV to Free Cash Flow44.45
EV to Operating Cash Flow38.49
Balance Sheet
Fisher & Paykel Healthcare Corporation Limited has $300.00M in cash and marketable securities with $148.20M in debt, giving a net cash position of $151.80M billion.
Cash & Marketable Securities$300.00M
Total Debt$148.20M
Net Cash$151.80M
Net Cash Per Share$0.26
Tangible Book Value Per Share$2.86
Margins
Gross margin is 63.58%, with operating margin of 25.22%, and net profit margin of 18.66%.
Gross Margin63.58%
Operating Margin25.22%
Pretax Margin24.90%
Net Profit Margin18.66%
EBITDA Margin30.80%
EBIT Margin25.22%
Analyst Forecast
The average price target for Fisher & Paykel Healthcare Corporation Limited is $46.92, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$46.92
Price Target Upside23.37% Upside
Analyst ConsensusModerate Buy
Analyst Count8
Revenue Growth Forecast15.55%
EPS Growth Forecast144.15%